Login / Signup

Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder ('CANSLEEP' trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial.

Anastasia SuraevRonald R GrunsteinNathaniel S MarshallAngela L D'RozarioChristopher J GordonDelwyn J BartlettKeith WongBrendon J YeeRyan VandreyChris IrwinJonathon C ArnoldIain S McGregorCamilla M Hoyos
Published in: BMJ open (2020)
ANZCTRN12619000714189.
Keyphrases
  • study protocol
  • placebo controlled
  • phase iii
  • phase ii
  • clinical trial
  • double blind
  • open label
  • randomized controlled trial
  • squamous cell carcinoma
  • radiation therapy